Anderson, Kenneth C; Auclair, Daniel; Kelloff, Gary J; Sigman, Caroline C; Avet-Loiseau, Herve; Farrell, Ann T; Gormley, Nicole J; Kumar, Shaji K; Landgren, Ola; Munshi, Nikhil C; Cavo, Michele; Davies, Faith E; Di Bacco, Alessandra; Dickey, Jennifer S; Gutman, Steven I; Higley, Howard R; Hussein, Mohamad A; Jessup, J Milburn; Kirsch, Ilan R; Little, Richard F; Loberg, Robert D; Lohr, Jens G; Mukundan, Lata; Omel, James L; Pugh, Trevor J; Reaman, Gregory H; Robbins, Michael D; Sasser, A Kate; Valente, Nancy; Zamagni, Elena, The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications, «CLINICAL CANCER RESEARCH», 2017, 23, pp. 3980 - 3993 [Scientific article]
Forte, Dorian; Salvestrini, Valentina; Corradi, Giulia; Rossi, Lara; Catani, Lucia; Lemoli, ROBERTO MASSIMO; Cavo, Michele; Curti, Antonio, The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling, «ONCOTARGET», 2017, 8, pp. 2261 - 2274 [Scientific article]
Lebret, T; Casas, A; Cavo, Michele; Woll, P. J; Deleplace, C; Kennedy, C; Schoen, P; Jackisch, C., The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey, «EUROPEAN JOURNAL OF CANCER CARE», 2017, 26, Article number: e12490 , pp. 1 - 16 [Scientific article]
Zamagni, Elena; Cavo, Michele, Toward a GEP-based PET in myeloma, «BLOOD», 2017, 130, pp. 2 - 3 [Scientific article]
Gugliotta, Gabriele; Sudo, Makoto; Cao, Qi; Lin, De-chen; Sun, Haibo; Takao, Sumiko; Le Moigne, Ronan; Rolfe, Mark; Gery, Sigal; Müschen, Markus; Cavo, Michele; Koeffler, H. Phillip, Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia, «NEOPLASIA», 2017, 19, pp. 750 - 761 [Scientific article]Open Access
Simonetti, Giorgia; Padella, Antonella; Manfrini, Marco; FARIA DO VALLE, Italo; Papayannidis, Cristina; Baldazzi, Carmen; Fontana, MARIA CHIARA; Guadagnuolo, Viviana; Ferrari, Anna; Zago, Elisa; Garonzi, Marianna; Bernardi, Simona; Astolfi, Annalisa; Abbenante, Mariachiara; Marconi, Giovanni; Zuffa, Elisa; Franchini, Eugenia; Lacobucci, Ilaria; Cavo, Michele; Ottaviani, Emanuela; Testoni, Nicoletta; Ferrarini, Alberto; Delledonne, Massimo; Haferlach, Torsten; Remondini, Daniel; Martinelli, Giovanni, A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia, «CANCER RESEARCH», 2016, 76, pp. 90 - 90 [Abstract]
Weisel, Katja C; Dimopoulos, Meletios A; Moreau, Philippe; Lacy, Martha Q; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Banos, Anne; Oriol, Albert; Alegre, Adrian; Chen, Christine; Cavo, Michele; Garderet, Laurent; Ivanova, Valentina; Martinez-Lopez, Joaquin; Knop, Stefan; Yu, Xin; Hong, Kevin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; San Miguel, Jesus, Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma, «HAEMATOLOGICA», 2016, 101, pp. 872 - 878 [Scientific article]Open Access
Dimopoulos, Meletios A; Moreau, Philippe; Palumbo, Antonio; Joshua, Douglas; Pour, Ludek; Hájek, Roman; Facon, Thierry; Ludwig, Heinz; Oriol, Albert; Goldschmidt, Hartmut; Rosiñol, Laura; Straub, Jan; Suvorov, Aleksandr; Araujo, Carla; Rimashevskaya, Elena; Pika, Tomas; Gaidano, Gianluca; Weisel, Katja; Goranova-Marinova, Vesselina; Schwarer, Anthony; Minuk, Leonard; Masszi, Tamás; Karamanesht, Ievgenii; Offidani, Massimo; Hungria, Vania; Spencer, Andrew; Orlowski, Robert Z; Gillenwater, Heidi H; Mohamed, Nehal; Feng, Shibao; Chng, Wee-Joo; Cavo, M, Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study, «THE LANCET ONCOLOGY», 2016, 17, pp. 27 - 38 [Scientific article]
Maria Chiara Fontana, Viviana Guadagnuolo, Cristina Papayannidis, Giovanni Marconi, Giorgia Simonetti, Antonella Padella, Marco Manfrini, Barbara Santacroce, Margherita Perricone, Silvia Lo Monaco, Emanuela Ottaviani, Simona Soverini, Michele Cavo, Giovanni Martinelli, Chromothripsis in AML patients: A new mechanism of cancer initiation and progression, «CANCER RESEARCH», 2016, 76, pp. 3582 - 3582 [Abstract]
Sollazzo, Daria; Forte, Dorian; Polverelli, Nicola; Perricone, Margherita; Romano, Marco; Luatti, Simona; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca; Catani, Lucia, Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly, «MEDIATORS OF INFLAMMATION», 2016, 2016, Article number: 5860657 , pp. 5860657 - 5860664 [Scientific article]Open Access
Soverini, Simona; DE BENEDITTIS, Caterina; Papayannidis, Cristina; Polakova, K. Machova; Venturi, Claudia; Russo, D; Bresciani, P; Iurlo, A; Mancini, Manuela; Vitale, A; Chiaretti, S; Foà, R; Abruzzese, E; Sorà, F; Kohlmann, A; Haferlach, T; Baccarani, Michele; Cavo, Michele; Martinelli, Giovanni, Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients, «LEUKEMIA», 2016, 30(7), pp. 1615 - 1619 [Scientific article]
Baldazzi, Carmen; Luatti, Simona; Zuffa, Elisa; Papayannidis, Cristina; Ottaviani, Emanuela; Marzocchi, Giulia; Ameli, Gaia; Bardi, Maria Antonella; Bonaldi, Laura; Paolini, Rossella; Gurrieri, Carmela; Rigolin, Gian Matteo; Cuneo, Antonio; Martinelli, Giovanni; Cavo, Michele; Testoni, Nicoletta, Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities, «GENES, CHROMOSOMES & CANCER», 2016, 55, pp. 375-88 - 388 [Scientific article]
Sollazzo, Daria; Forte, Dorian; Polverelli, Nicola; Romano, Marco; Perricone, Margherita; Rossi, Lara; Ottaviani, Emanuela; Luatti, Simona; Martinelli, Giovanni; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca; Catani, Lucia, Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study, «ONCOTARGET», 2016, 7, pp. 43974 - 43988 [Scientific article]
Pantani, L; Brioli, A; Tacchetti, P; Zannetti, B A; Mancuso, K; Rocchi, Serena; Martello, M; Rizzello, I; Terragna, C; Zamagni, E; Cavo, M, Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma, «EXPERT REVIEW OF HEMATOLOGY», 2016, 9, pp. 315 - 323 [Scientific article]Open Access
Palumbo, Antonio; Chanan Khan, Asher; Weisel, Katja; Nooka, Ajay K.; Masszi, Tamas; Beksac, Meral; Spicka, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria V.; Mark, Tomer M.; Ming, Qi; Schecter, Jordan; Amin, Himal; Qin, Xiang; Deraedt, William; Ahmadi, Tahamtan; Spencer, Andrew; Sonneveld, Pieter; Cavo, Michele, Daratumumab, bortezomib, and dexamethasone for multiple myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2016, 375, pp. 754 - 766 [Scientific article]
